drugset / Trial / NCT03484741
Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients
Phase 1/2
Unknown
15 enrolled
Van Hanh General Hospital
University of Science Ho Chi Minh City · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) transplantation for type 1 Diabetes Mellitus patients.
Timeline
- Start
- 2017-04-01
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | — | Intravenous |
| Background | Platelet Rich Plasma | Other / unclassified | — | Intravenous |